A new study from Queen’s University professor Christopher Booth has revealed the pricing of cancer drugs appears to have no relationship to their effectiveness.
Through the review it was revealed that the most expensive drugs were not the most beneficial.
“Most members of the public (and many patients) may not understand that when they read about a new ‘breakthrough cancer therapy’ in the media it usually does not cure cancer but extends survival by a few weeks or perhaps a few months,” says Dr. Booth (Oncology). “Given that these drugs are very expensive and have important side effects, these small improvements may not lead to real improvements in the overall health and well-being of our patients or society as a whole.”
Read Full Article Here >>